Cyclerion Therapeutics, Inc is a biotechnology business based in the US. Cyclerion Therapeutics shares (CYCN) are listed on the NASDAQ and all prices are listed in US Dollars. Cyclerion Therapeutics employs 34 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Cyclerion Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CYCN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Cyclerion Therapeutics stock price (NASDAQ: CYCN)Use our graph to track the performance of CYCN stocks over time.
Cyclerion Therapeutics shares at a glance
|Latest market close||$3.24|
|52-week range||$2.08 - $8.96|
|50-day moving average||$3.73|
|200-day moving average||$3.46|
|Wall St. target price||$4.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-4.74|
Buy Cyclerion Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Cyclerion Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cyclerion Therapeutics price performance over time
|1 week (2021-07-16)||N/A|
|1 month (2021-06-25)||-20.59%|
|3 months (2021-04-27)||26.56%|
|6 months (2021-01-23)||N/A|
|1 year (2020-07-23)||N/A|
|2 years (2019-07-23)||N/A|
|3 years (2018-07-23)||N/A|
|5 years (2016-07-23)||N/A|
Cyclerion Therapeutics financials
|Revenue TTM||$1.3 million|
|Gross profit TTM||$2.3 million|
|Return on assets TTM||-36.06%|
|Return on equity TTM||-109.21%|
|Market capitalisation||$166.9 million|
TTM: trailing 12 months
Shorting Cyclerion Therapeutics shares
There are currently 1.9 million Cyclerion Therapeutics shares held short by investors – that's known as Cyclerion Therapeutics's "short interest". This figure is 41.5% down from 3.2 million last month.
There are a few different ways that this level of interest in shorting Cyclerion Therapeutics shares can be evaluated.
Cyclerion Therapeutics's "short interest ratio" (SIR)
Cyclerion Therapeutics's "short interest ratio" (SIR) is the quantity of Cyclerion Therapeutics shares currently shorted divided by the average quantity of Cyclerion Therapeutics shares traded daily (recently around 2.6 million). Cyclerion Therapeutics's SIR currently stands at 0.71. In other words for every 100,000 Cyclerion Therapeutics shares traded daily on the market, roughly 710 shares are currently held short.
However Cyclerion Therapeutics's short interest can also be evaluated against the total number of Cyclerion Therapeutics shares, or, against the total number of tradable Cyclerion Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cyclerion Therapeutics's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Cyclerion Therapeutics shares in existence, roughly 50 shares are currently held short) or 0.0738% of the tradable shares (for every 100,000 tradable Cyclerion Therapeutics shares, roughly 74 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Cyclerion Therapeutics.
Find out more about how you can short Cyclerion Therapeutics stock.
Cyclerion Therapeutics share dividends
We're not expecting Cyclerion Therapeutics to pay a dividend over the next 12 months.
Cyclerion Therapeutics share price volatility
Over the last 12 months, Cyclerion Therapeutics's shares have ranged in value from as little as $2.08 up to $8.96. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cyclerion Therapeutics's is 1.8576. This would suggest that Cyclerion Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cyclerion Therapeutics overview
Cyclerion Therapeutics, Inc. , a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its product candidates include CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase II trials for the treatment of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) and Alzheimer's disease with vascular pathology (ADv); Olinciguat, an orally administered vascular soluble guanylate cyclase stimulator that is in Phase II studies for the treatment of sickle cell disease (SCD); Praliciguat, an orally administered systemic sGC stimulator that is in Phase II trials for the treatment of diabetic nephropathy and heart failure with preserved ejection fraction. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts. .
Stocks similar to Cyclerion Therapeutics
Cyclerion Therapeutics in the news
75 Biggest Movers From Friday
The Week Ahead In Biotech: Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
Frequently asked questionsWhat percentage of Cyclerion Therapeutics is owned by insiders or institutions?
Currently 14.708% of Cyclerion Therapeutics shares are held by insiders and 57.414% by institutions. How many people work for Cyclerion Therapeutics?
Latest data suggests 34 work at Cyclerion Therapeutics. When does the fiscal year end for Cyclerion Therapeutics?
Cyclerion Therapeutics's fiscal year ends in December. Where is Cyclerion Therapeutics based?
Cyclerion Therapeutics's address is: 301 Binney Street, Cambridge, MA, United States, 02142 What is Cyclerion Therapeutics's ISIN number?
Cyclerion Therapeutics's international securities identification number is: US23255M1053 What is Cyclerion Therapeutics's CUSIP number?
Cyclerion Therapeutics's Committee on Uniform Securities Identification Procedures number is: 23255M105
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy HNC Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert